113
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Multicenter evaluation of IV acyclovir use prior to, during, and after a national shortage*

, , , , &
Pages 778-780 | Received 10 Apr 2017, Accepted 24 Apr 2017, Published online: 17 May 2017
 

Disclosure statement

The authors have no conflicts of interest to declare relative to this study. J.S.E. is currently an employee of Merck, Inc. At the time of data collection, analysis, and article writing, J.S.E. was not affiliated with Merck, Inc.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.